Boston Partners
AVNS

Boston Partners’s Avanos Medical AVNS Stock Holding History

Boston Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,685
Closed -$571K – 713
2024
Q1 		$571K Buy
+28,685
New +$554K ﹤0.01% 674

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Boston Partners's AVNS Position: Q2 2024 in Review

Boston Partners sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 28,685 shares — an estimated $571K sold.

Boston Partners first reported a position in AVNS in Q1 2024 and held it in 1 quarter. The position peaked at $571K in Q1 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Boston Partners reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Boston Partners sold 28,685 Avanos Medical shares in Q2 2024, an estimated $571K.
  • Boston Partners first reported a position in Avanos Medical in Q1 2024 and held it in 1 quarter.
  • Boston Partners's Avanos Medical position peaked at $571K in Q1 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.